Navegar por autor "Carmona Ortells, Loreto"

Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry

2011- Gómez-Reino Carnota, Juan Jesús; Carmona Ortells, Loreto

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries

2023- Machado, P.M.; Schäfer, M.; Mahil, S.K.; Liew, J.; Gossec, L.; [et al.]

Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review

2011- Gómez-Reino Carnota, Juan Jesús; Carmona Ortells, Loreto

Efficacy and Safety of TNF Antagonists in Sarcoidosis: Data from the Spanish Registry of Biologics BIOBADASER and a Systematic Review

2012- Gómez-Reino Carnota, Juan Jesús; Maneiro Fernández, José Ramón; Salgado Pérez, Eva; Carmona Ortells, Loreto

El uso de abatacept en artritis reumatoide: Revisión de la evidencia y recomendaciones

2013- Gómez-Reino Carnota, Juan Jesús; Carmona Ortells, Loreto

High Sodium Intake Is Associated With Self-Reported Rheumatoid Arthritis: A Cross Sectional and Case Control Analysis Within the SUN Cohort

2015- Salgado Pérez, Eva; Bes-Rastrollo, M.; de Irala, J.; Carmona Ortells, Loreto; Gómez-Reino Carnota, Juan Jesús [et al.]

Influence of Baseline Rheumatoid Factor on the Response to Tumor Necrosis Factor Antagonists of Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis

2011- Gómez-Reino Carnota, Juan Jesús; Maneiro Fernández, José Ramón; Salgado Pérez, Eva; Carmona Ortells, Loreto

Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: A systematic review and meta-analysis

2015- Gómez-Reino Carnota, Juan Jesús; Maneiro Fernández, José Ramón; Salgado Pérez, Eva; Carmona Ortells, Loreto; Souto Vilas, Alejandro [et al.]

Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience

2014- Gómez-Reino Carnota, Juan Jesús; Pérez Pampín, Eva; Maneiro Fernández, José Ramón; Salgado Pérez, Eva; Carmona Ortells, Loreto [et al.]

Practice guidelines for the use of subcutaneous abatacept

2014- Gómez-Reino Carnota, Juan Jesús; Carmona Ortells, Loreto

Rheumatoid factor and response to anti-TNF in rheumatoid arthritis: Systematic review and meta-analysis of observational studies

2014- Gómez-Reino Carnota, Juan Jesús; Maneiro Fernández, José Ramón; Salgado Pérez, Eva; Carmona Ortells, Loreto

Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: Systematic review and meta-analysis of observational studies

2013- Gómez-Reino Carnota, Juan Jesús; Maneiro Fernández, José Ramón; Salgado Pérez, Eva; Carmona Ortells, Loreto

Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: systematic review and meta-analysis of observational studies

2014- Gómez-Reino Carnota, Juan Jesús; Maneiro Fernández, José Ramón; Salgado Pérez, Eva; Carmona Ortells, Loreto

Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis

2013- Gómez-Reino Carnota, Juan Jesús; Maneiro Fernández, José Ramón; Salgado Pérez, Eva; Carmona Ortells, Loreto

Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: Three centers experience

2013- Gómez-Reino Carnota, Juan Jesús; Pérez Pampín, Eva; Salgado Pérez, Eva; Carmona Ortells, Loreto

Rheumatoid factor does not seem to predict response to anti-TNFα in rheumatoid arthritis: Experience of three centers

2013- Gómez-Reino Carnota, Juan Jesús; Pérez Pampín, Eva; Salgado Pérez, Eva; Carmona Ortells, Loreto

Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies

2014- Souto Vilas, Alejandro; Maneiro Fernández, José Ramón; Salgado Pérez, Eva; Carmona Ortells, Loreto; Gómez-Reino Carnota, Juan Jesús [et al.]

Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis

2014- Gómez-Reino Carnota, Juan Jesús; Maneiro Fernández, José Ramón; Salgado Pérez, Eva; Carmona Ortells, Loreto

Systematic review of the safety of protein kinase inhibitors in clinical trials in rheumatoid arthritis

2013- Gómez-Reino Carnota, Juan Jesús; Maneiro Fernández, José Ramón; Salgado Pérez, Eva; Carmona Ortells, Loreto

The effect of rheumatoid factor titer on the response to TNF antagonists

2013- Gómez-Reino Carnota, Juan Jesús; Pérez Pampín, Eva; Salgado Pérez, Eva; Carmona Ortells, Loreto

Repositorio digital RUNA

Navegar por autor "Carmona Ortells, Loreto"

Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry ﻿

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries ﻿

Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review ﻿

Efficacy and Safety of TNF Antagonists in Sarcoidosis: Data from the Spanish Registry of Biologics BIOBADASER and a Systematic Review ﻿

El uso de abatacept en artritis reumatoide: Revisión de la evidencia y recomendaciones ﻿

High Sodium Intake Is Associated With Self-Reported Rheumatoid Arthritis: A Cross Sectional and Case Control Analysis Within the SUN Cohort ﻿

Influence of Baseline Rheumatoid Factor on the Response to Tumor Necrosis Factor Antagonists of Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis ﻿

Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: A systematic review and meta-analysis ﻿

Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience ﻿

Practice guidelines for the use of subcutaneous abatacept ﻿

Rheumatoid factor and response to anti-TNF in rheumatoid arthritis: Systematic review and meta-analysis of observational studies ﻿

Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: Systematic review and meta-analysis of observational studies ﻿

Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: systematic review and meta-analysis of observational studies ﻿

Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis ﻿

Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: Three centers experience ﻿

Rheumatoid factor does not seem to predict response to anti-TNFα in rheumatoid arthritis: Experience of three centers ﻿

Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies ﻿

Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis ﻿

Systematic review of the safety of protein kinase inhibitors in clinical trials in rheumatoid arthritis ﻿

The effect of rheumatoid factor titer on the response to TNF antagonists ﻿

Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries

Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review

Efficacy and Safety of TNF Antagonists in Sarcoidosis: Data from the Spanish Registry of Biologics BIOBADASER and a Systematic Review

El uso de abatacept en artritis reumatoide: Revisión de la evidencia y recomendaciones

High Sodium Intake Is Associated With Self-Reported Rheumatoid Arthritis: A Cross Sectional and Case Control Analysis Within the SUN Cohort

Influence of Baseline Rheumatoid Factor on the Response to Tumor Necrosis Factor Antagonists of Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis

Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: A systematic review and meta-analysis

Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience

Practice guidelines for the use of subcutaneous abatacept

Rheumatoid factor and response to anti-TNF in rheumatoid arthritis: Systematic review and meta-analysis of observational studies

Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: Systematic review and meta-analysis of observational studies

Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: systematic review and meta-analysis of observational studies

Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis

Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: Three centers experience

Rheumatoid factor does not seem to predict response to anti-TNFα in rheumatoid arthritis: Experience of three centers

Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies

Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis

Systematic review of the safety of protein kinase inhibitors in clinical trials in rheumatoid arthritis

The effect of rheumatoid factor titer on the response to TNF antagonists